Delivery Order SPE2DB22D1106-SPE2DB25FDTW4

Award Date 1/10/25
Potential Completion Date 1/13/25
Potential Value $55K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide the drug WEGOVY 2.4 mg/0.75 ml pen (0.75 ml). The contract has a ceiling value of $9,855.14 and runs through November 29, 2024. It is a delivery order contract with a firm fixed price pricing type. The contract was not set aside for any specific business category. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the drug WEGOVY 1.7 MG/0.75 ML PEN 0.75ML. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 held by AmerisourceBergen with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,209.72 firm-fixed-price delivery order is for the supply of the drug WEGOVY 1 MG/0.5 ML PEN 0.5ML. The contract has an ultimate completion date of March 25, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
This is a federal contract award by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $30,576.59, is for the delivery of the drug WEGOVY 0.25 MG/0.5 ML PEN 0.5ML. This is a firm fixed-price delivery order contract with a completion date of January 9, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen also...
This federal contract award, valued at $24,979.50, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the medication WEGOVY 0.25 MG/0.5 ML PEN 0.5ML, a specialty pharmaceutical product. The contract has an ultimate completion date of December 17, 2024 and is a firm fixed-price delivery order. The contract is not designated as a set-aside. AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,583.28 delivery order is for the medication WEGOVY 0.25 MG/0.5 ML PEN 0.5ML. The contract has a firm fixed price and an ultimate completion date of November 14, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for...
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,228.50, is for the delivery of the drug product WEGOVY 1.7 MG/0.75 ML PEN 0.75ML. This is a firm fixed-price delivery order contract with a completion date of January 13, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract has an award value of $26,279.93 and is for the delivery of the pharmaceutical product WEGOVY 0.5 MG/0.5 ML PEN 0.5ML. The contract has an ultimate completion date of December 30, 2024 and is a Firm Fixed Price Delivery Order. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award, valued at $2,600.70, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a Delivery Order under an Indefinite Delivery Contract (IDC), is for the supply of the medication WEGOVY 1 MG/0.5 ML PEN 0.5ML. The award has an ultimate completion date of December 19, 2024 and a firm fixed price pricing type. This contract is not designated as a set-aside. As a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,338.75, is for the delivery of the medication WEGOVY 1.7 MG/0.75 ML PEN 0.75ML. This is a Firm Fixed Price Delivery Order contract with a period of performance through January 3, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB25FDTW4
    Delivery Order

This federal contract award, with a ceiling value of $54,508.63, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the drug WEGOVY 1.7 MG/0.75 ML PEN 0.75ML, with an ultimate completion date of January 13, 2025. The contract is a firm fixed-price agreement, and there is no set-aside designation mentioned. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 4/13/25, 12:50 AM